DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

Celldex Therapeutics (NASDAQ: CLDX)

23.55 0.03 (0.13%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

CLDX $23.55 0.13%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $23.66
Previous Close $23.52
Daily Range $23.26 - $24.23
52-Week Range $12.11 - $32.82
Market Cap $2.3B
P/E Ratio -17.82
Dividend (Yield) $0.00 (0.0%)
Volume 1,075,882
Average Daily Volume 1,230,651
Current FY EPS -$1.40

Sector

Healthcare

Industry

Drug Makers

Celldex Therapeutics (CLDX) Description

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease. Website: http://www.celldex.com/

News & Commentary Rss Feed

3 Experimental Cancer Drugs Investors Should Be Closely Watching

Meet the drugs our experts believe have shown the most promising results in the race to cure cancer.

Weak On High Volume: Celldex Therapeutics (CLDX)

Strong On High Relative Volume: Celldex Therapeutics (CLDX)

Celldex Therapeutics Still Looks Undervalued With Multiple Clinical Shots On Goal

Celldex's Rintega Phase III Study Recommended to Continue - Analyst Blog

Celldex's Rintega Phase III Study Recommended to Continue - Analyst Blog

Celldex Therapeutics (CLDX) Is Today's Dead Cat Bounce Stock

Making Big Bucks with Biotech: Why the P-Test is Key

Understand the connection between statistics and biotech stocks.

These 3 Biotech Stocks Are Losing Money, But We'd Still Buy Them

Nearly 90% of biotech stocks are losing money, but that doesn't mean our healthcare analysts don't perceive there to be value in the sector.

This Terrifying Cancer May Finally Be Treatable

Celldex Therapeutics reported some highly encouraging data for its experimental brain cancer vaccine Rintega at the recent ASCO meeting. Could this vaccine prove to be a game-changer in the fight against this deadly disease?

Biotech Stock Mailbag: More Duchenne Drama, CAR-T Trouble, ASCO '15 Rewind

See More CLDX News...

CLDX's Top Competitors

CLDX $23.55 (0.13%)
Current stock: CLDX
AMGN $176.59 (2.85%)
Current stock: AMGN
GILD $117.86 (-0.03%)
Current stock: GILD
BIIB $318.78 (0.56%)
Current stock: BIIB